Literature DB >> 25417400

Traditional Chinese medicine for the treatment of influenza: a systematic review and meta-analysis of randomized controlled trials.

Chunya Wang, Hao Wang, Xinying Liu, Dongping Xu, Yipang Tang, Ping Luo.   

Abstract

OBJECTIVE: To justify the clinical use of Traditional Chinese Medicine (TCM) in the treatment of influenza.
METHODS: MEDLINE, EMBASE, Chinese Biomedical Literature Database, China National Knowledgeln-frastructure Database, China Science and Technology Journal Database, Wanfang Database and the Cochrane Database of Systematic Reviews were searched from the date of inception until January 1, 2013, for the literature on treatment of influenza with TCM.
RESULTS: A total of 7 randomized controlled trials were identified and reviewed. Of these trials, 2 compared a (modified) prescription of TCM with oseltacmivir and 5 compared a patent traditional Chinese drug with oseltamivir. Based on the Meta-analysis, compared to oseltamivir, the (modified) prescription had similar effect in defervescence [WMD = 5.66, 95% CI (- 32.02, 43.35), P = 0.77] and viral sheddingWMD = - 6.21, 95% CI (- 84.19, 71.76), P = 0.88], and the patent traditional Chinese drug also had similar effect in viral shedding [WMD = - 0.24, 95% CI (- 4.79, 4.31), P = 0.92] but more effective in defervescence [WMD = - 4.65, 95%CI (- 8.91, - 0.38),P = 0.03].
CONCLUSION: TCM has potential positive effects in the treatment of influenza.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25417400     DOI: 10.1016/s0254-6272(15)30057-1

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN: 0255-2922            Impact factor:   0.848


  4 in total

Review 1.  Toxicity as prime selection criterion among SARS-active herbal medications.

Authors:  Franz Oesch; Barbara Oesch-Bartlomowicz; Thomas Efferth
Journal:  Phytomedicine       Date:  2021-01-28       Impact factor: 5.340

2.  Effectiveness of Chinese patent medicine in the treatment of influenza: A protocol for systematic review and meta-analysis.

Authors:  Kang Liu; Yongkang Zhang; Xin Song
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

3.  Treatment of COVID-19 in Hemodialysis Patients Using Traditional Chinese Medicine: A Single-Center, Retrospective Study.

Authors:  Wei Huang; Bo Jiang; Jinli Luo; Meng Luo; Xiaoming Ding; Qian Yang; Lin-Hua Zhao; Qin-Guo Sun; Xiao-Lin Tong
Journal:  Front Pharmacol       Date:  2022-03-24       Impact factor: 5.810

4.  Traditional Chinese Medicine Injections Combined With Oseltamivir for Influenza: Systematic Review and Network Meta-Analysis.

Authors:  Yingying Peng; Zhe Chen; Huanmin Li; Yaowei Han; Dan Sun; Yanjiao Li; Xiaoxia Wu; Hongxiang Chen; Xinmin Li
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.